The following data is part of a premarket notification filed by Alliqua Biomedical, Inc with the FDA for Silverseal.
Device ID | K171041 |
510k Number | K171041 |
Device Name: | SilverSeal |
Classification | Dressing, Wound, Drug |
Applicant | Alliqua BioMedical, Inc 2150 Cabot Boulevard West Suite B Langhorne, PA 19047 |
Contact | Johanna Reinert |
Correspondent | Johanna Reinert Alliqua BioMedical, Inc 2150 Cabot Boulevard West Suite B Langhorne, PA 19047 |
Product Code | FRO |
CFR Regulation Number | 510(k) Premarket Notification [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | Yes |
Date Received | 2017-04-07 |
Decision Date | 2017-08-22 |
Summary: | summary |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SILVERSEAL 90819933 not registered Live/Pending |
SILVERSEAL CORPORATION 2021-07-09 |
SILVERSEAL 81007265 1007265 Dead/Cancelled |
Lee Pharmaceuticals 0000-00-00 |
SILVERSEAL 76465747 2887226 Live/Registered |
NOBLE FIBER TECHNOLOGIES, LLC 2002-11-12 |
SILVERSEAL 73280409 not registered Dead/Abandoned |
GULFKO, INCORPORATED 1980-10-06 |